The soluble leptin receptor (sOB-R) was recently identified as the main leptin-binding protein in human blood. The aim of our study was to elucidate the effects of physiologically relevant amounts of sOB-R on leptin-induced proliferation in a cell model.
Introduction
Leptin, the adipocyte-derived hormone, acts as a regulating factor for food intake and energy homeostasis via its specific receptor in the hypothalamus. [1] [2] [3] Moreover, recent data suggest that leptin affects a wide range of metabolic functions in peripheral tissues and it controls processes within the reproductive axis. 4 Produced by adipocytes, that constitute the architectural basis for the bone marrow cavity, leptin was also found to increase the colony-forming activity of lymphoid, myeloid and erythroid lines in vitro. Therefore, leptin seems to exert proliferative actions in cells of the haematopoietic lineage via the leptin receptor present in stem cell populations. 5, 6 The leptin receptor (OB-R) is expressed in at least four variants in human tissue as well as in at least five splice variants (OB-Ra-e) in mice, at variance in the length of their cytoplasmatic domains. [7] [8] [9] The long form (OB-Rb), occurring predominantly in hypothalamic nuclei, conducts the full signal transducing activities. 10 Postsignal mechanisms result in the above-mentioned anorectic effects or else in an induction of proliferative signals. 11 Functions of the short receptor variants, which are expressed almost ubiquitously in human tissue, are less clear. Deficient in essential motifs of the cytoplasmatic domain, OB-Ra is supposed to account for transport functions, most likely in the choroid plexus. 12 The soluble leptin receptor (sOB-R) represents the main leptin-binding activity in human blood. This protein circulates in two different N-glycosylated isoforms, as a dimer or in an oligomerized state. 13 Complexes of leptin with sOB-R reflect a molecular ratio of 1 : 1. 14 In mice, alternative splicing results in different OB-R variants including its soluble isoform. 9 Additionally, the sOB-R was shown to be generated by ectodomain shedding of membranebound receptor forms. 15 Experimental data are evident in humans showing that sOB-R is produced similarly by a metalloprotease-mediated cleavage, 16 whereas no mRNA for a splice form encoding the sOB-R has been detected so far. 17 This receptor isoform could modulate steady-state leptin levels by complexing free leptin in the circulation and consequently preventing the hormone from degradation and clearance. 18 Therefore, high sOB-R levels in the blood, as determined in lean humans, 19 may act as a potential reservoir of bioactive leptin. Decreasing amounts of sOB-R, observed in states of progressing obesity or during ageing processes, could result in augmented levels of liberated bioactive leptin. [20] [21] [22] [23] However, the physiological function of the circulating OB-R has not been systematically investigated to date. Besides, the impact of sOB-R on leptin action on cells is unknown. To elucidate this issue, we determined the effect of varying molar ratios of leptin and the soluble receptor on the proliferation of mouse pre-B cells transfected with the long form of the murine leptin receptor (BAF3/L46). 10 In order to investigate the putative clinical significance of results obtained in in vitro experiments, cells were incubated with sOB-R and leptin concentrations corresponding to circulating levels of both proteins in the serum of boys and girls during childhood, puberty and adolescence.
Methods

Subjects
Blood was drawn in the supine position from an antecubital vein between 08.00 a.m. and 10.00 a.m., from patients during routine investigations as well as from children participating in the 'Schulkinderprojekt Leipzig' (n ¼ 265 male and 264 female patients). All subjects were free of acute and chronic diseases as well as of endocrine-related illnesses. Detailed data describing our subjects were published recently. 24 Laboratory methods Levels of sOB-R in the serum were measured by a newly developed 'in-house' ligand immunofunctional assay (LIFA). 13 Briefly, wells of a microtiter plate were coated with an anti-sOB-R IgG (rabbit; R&D, Wiesbaden, Germany) and nonspecific binding was blocked with 0.1% bovine serum albumin (BSA) in PBS for 1 h. The sOB-R standard (R&D, Wiesbaden, Germany) or serum samples and an excess of biotinylated leptin in assay buffer were supplied to particular wells. Complexes of sOB-R and biotinylated leptin were detected by Europium-labelled streptavidin (Perkin-Elmer, Freiburg, Germany). Fluorescence signals of Europium were measured by the Victor-system (PerkinElmer, Freiburg, Germany). Intraassay and interassay coefficients of variation for two control samples were lower than 11.7% (n ¼ 10) and dilution; in addition, sOB-R spiking experiments showed a recovery of 97.2711.8% and 92.478.6% (n ¼ 10). This assay was nearly insensitive to the interference of leptin, verified by using leptin levels up to 50 ng/ml, which provoked a decrease of 6.472.7% after linear regression analysis. Leptin levels in male and female subjects were determined by an 'in-house' radioimmunoassay (RIA) 25 with an intraassay and interassay coefficient of variation lower than 12.5% in a range between 1 and 8 ng/ml leptin. Leptin levels of this ''in-house'' RIA (x) were highly correlated to data of a commercially available leptin RIA (y) (Mediagnost, Tuebingen, Germany) in sera of normal weight and obese subjects (y ¼ À0.13 þ 0.96 x (n ¼ 92, r ¼ 0.94, Po0.0001)).
BAF3 cells and cell culture. BAF3 cells, transfected with the cDNA encoding for either the long splice variant of the murine leptin receptor (BAF3/L46) or its short form (BAF3/ S29), as well as nontransfected cells (BAF3/NT), 26 were a gift from RC Skoda (Basel, Switzerland). Cells were maintained in RPMI 1640 medium (Invitrogen, Karlsruhe, Germany), supplemented with 0.1 mg/ml penicillin/streptomycin and 2 mM L-glutamine (Biochrom KG, Berlin, Germany). Fetal calf serum (FCS; Biochrom KG, Berlin, Germany), heat inactivated for 30 min at 561C, was added to this culture medium to a final concentration of 10%. The addition of 2 ng/ml interleukin 3 (IL-3; Peprotech, London, UK) was in agreement with the dependence of BAF3 cells on this cytokine in the medium. BAF3/L46, S29 and NT cells were cultivated in a humidified CO 2 incubator (371C/5% CO 2 ).
Incubation of BAF3 /L46 cells with varying levels of human and murine leptin. An in vitro cell model for the quantification of leptin actions, evaluated for the murine system according to Ghilardi and Skoda, 10 was adapted for human leptin. In detail, BAF3/L46 cells, expressing the long isoform of the murine leptin receptor, were incubated with human leptin (R&D, Wiesbaden, Germany) in an assay medium (RPMI 1640 medium, Invitrogen, Karlsruhe, Germany; 0.1 mg/ml antibiotics, 2 mM L-glutamine and 10% FCS (heat-inactivated), Biochrom KG, Berlin, Germany). The final leptin concentrations ranged from 6.25 pM to 3.2 nM. Subsequently, 50 ml aliquots were distributed into wells of a 96-well cell culture plate (TPP, Trasadingen, Switzerland). After three washing cycles with IL-3-free medium, 20 000 cells were added to each well in 50 ml assay medium and the plates were incubated for 48 h at 371C/5% CO 2 .
Incubation of BAF3/L46 cells with varying ratios between sOB-R and human leptin. A dilution series was prepared, resulting in the respective amounts of human sOB-R standard. Human leptin at two constant levels (0.5 nM and 0.1 nM) was added to these sOB-R dilutions, resulting in varying molar ratios between sOB-R and basal leptin levels ranging from a 10-fold excess of sOB-R down to a 10-fold excess of leptin. After overnight incubation (16 h) at 41C, H-thymidine (Amersham, Little Chalfont, UK) diluted in 50 ml assay medium was supplied to each well and the plates were incubated for 4 h at standard conditions. The cells were transferred onto glass fibre filters (Inotech, Dottikon, Switzerland) that were dried overnight and then distributed to counting tubes (Perkin-Elmer-Wallac, Turku, Finland).
3 H-thymidine uptake was measured in counts per minute (cpm) using a b-counter (Perkin-Elmer-Wallac, Freiburg, Germany). Cell assays were carried out by an eight-fold determination in two independent experiments. Nonspecific background counts of 3 H-thymidine in cell-free medium controls were subtracted from each of the results. Negative counting rates as well as proliferative rates 450 or o50% referred to the median at the particular stimulation level were excluded from further calculations. Results in cpm were standardized to the median values of the proliferative activity at the 3.2 nM leptin level or to the mitogenic activity at the basal leptin level, respectively.
Statistical analysis
Data of the leptin-induced cell proliferation as well as measured leptin and sOB-R levels presented a non-normal distribution. Therefore, nonparametric statistical methods (medians, quartile ranges and the U-test of Mann-Whitney, using the adjustment of Bonferroni) were selected for all analyses. Results were calculated using the program Statistica 5.0 (Statsoft, Tulsa, USA).
Results
Molar ratio between sOB-R and leptin levels in childhood and early puberty The course of the molar sOB-R/leptin ratio in the peripheral blood of healthy children and adolescents is depicted in Figure 1 . Detailed data of leptin and sOB-R levels were published by our group recently. 24 During the first years of life, a marked molar excess of sOB-R levels over leptin was present in sera of both genders. Interestingly, this sOB-R excess was in part significantly higher in boys (7.67; quartiles: 4.43/10.27) than in girls (3.43; quartiles: 3.14/ 4.63) (Po0.01). These higher sOB-R/leptin ratios in the male group were mainly a result of their lower leptin levels in total throughout all age groups. The observed decrease in the ratio between sOB-R and leptin during progressing childhood in both genders down to an equimolar ratio in boys and to a two-fold excess of leptin in girls was explained by declining amounts of the circulating receptor itself, paralleled by an increase in the absolute leptin level. Later, during puberty, the molar ratio reincreased to a 2.45-fold molar excess of the sOB-R (75th percentile) only in boys. This was again attributable at least in part to significantly decreased levels of leptin during late stages of pubertal development. In contrast, leptin levels of girls remained nearly unchanged in this period. Therefore, the particular sOB-R/leptin ratios decreased only in terms of dependence on the slightly diminished sOB-R values.
Effects of varying ratios between the sOB-R and leptin in a cell culture model In the next step, we examined the effects of varying levels of recombinant sOB-R on leptin-induced BAF3/L46 cell proliferation. The molar ratios between sOB-R and leptin used in these experiments, ranging from 10-fold excess of sOB-R to a 10-fold excess of leptin, were approximately in accordance with our in vivo data of children and adolescents.
In the absence of any sOB-R recombinant human leptin induced a dose-dependent increase in the proliferative response of the cells concurring to data observed in the murine model 10 ( Figure 2 ). Neither BAF3/S29 cells, expressing the short receptor isoform, nor nontransfected BAF3/NT cells were found to respond to exogenous leptin administration (data not shown). Furthermore, the leptin effect was apparent at a constant level of FCS present in the assay medium. In the absence of FCS, gradually increasing concentrations of leptin did not result in any proliferative response ( Figure 3) . Conversely, increasing FCS levels itself, in the absence of leptin, had no impact on 3 H-thymidine uptake of BAF3/L46 cells (data not shown).
Using this cell culture model, we were able to describe for the first time the modulating effects of varying sOB-R levels on the proliferative rate of cells: recombinant human leptin at two basal levels (0.5 nM and 0.1 nM) was coincubated with defined amounts of the respective sOB-R (Figure 4 ). An 
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O Zastrow et al increasing excess of sOB-R, at both leptin levels tested, resulted in a significant suppression of the basal proliferative activity of BAF3/L46 cells (Po0.001), whereas the sOB-R itself was not able to influence this proliferative rate in the absence of leptin (data not shown). The greatest excess of the sOB-R used in the experiment (10-fold) reduced the basal uptake of 3 H-thymidine to 27.5% at 0.5 nM and 37.8% at 0.1 nM leptin, respectively. Moreover, if the effect of the proliferative activity of the cells in the absence of leptin had been subtracted from these data, this uptake would have decreased to 14.5% at 0.5 nM and to 6.3% at 0.1 nM leptin. Although the absolute levels of the 3 H-thymidine uptake were increased at the higher basal leptin level, there was no significant dose dependency in the relative response of the cells.
Even minor ratios reflecting a five to two-fold excess of molar sOB-R over leptin resulted in a significant decrease of the potency of leptin to induce cell proliferation at both levels (Po0.01).
Gradually decreasing molar ratios between the sOB-R and leptin down to an equimolar ratio or to a molar excess of leptin led to proliferative rates that did not differ significantly from particular rates observed at basal conditions in the absence of sOB-R.
Discussion
In this study, we demonstrate for the first time that a molar excess of sOB-R in relation to leptin is apparent in early childhood. Furthermore, our data revealed that such a distinct excess of sOB-R can suppress leptin action in a cell model. Transforming these results from the experimental study back to the physiology of leptin we hypothesize that the circulating leptin receptor, when present in molar excess of two-fold or greater, suppresses leptin actions in vitro as well as in vivo. Thus, sOB-R excess may be one cause for at least partial leptin resistance at peripheral tissues.
Peripheral leptin levels are determined by variations in leptin secretion, leptin consumption and leptin clearance. On the one hand, the sOB-R may delay the clearance and Soluble leptin receptor and leptin action O Zastrow et al degradation of leptin. 26 The resulting increase in the leptin half-life has been described in murine pregnancy, where massively elevated levels of sOB-R may deliver leptin to target tissues, especially to the feto-placentar unit. 27, 28 Furthermore, an overexpression of sOB-R in ob/ob mice could also enhance the weight-reducing effects of leptin in vivo. 18 A possible explanation for this is a net increase of the free hormone in the circulation. On the other hand, a molar sOB-R excess may prevent the hormone from acting via the membrane bound receptor forms. This assumption is likely, taking the findings from our in vitro studies and the observation, showing that an approximately 10-fold molar excess of a soluble chimerical leptin receptor was capable of blocking leptin-induced effects in a murine epidermal keratinocyte cell model completely. 29 The higher sOB-R/leptin ratios in boys that we have observed throughout all age groups may contribute to the sexual dimorphism in the biological action of leptin during childhood and adolescence. Especially, a distinct molar excess of sOB-R as determined in sera of children during the initial years of life may have a modulating impact on leptin action. We speculate that levels of the bioactive hormone may be reduced in the circulation of young children, as food intake and energy storage are of great importance, particularly during a period of marked growth velocity as in the initial years of life. Later, during puberty, leptin released from its complex with the soluble receptor may act as a distinct metabolic signal. In detail, increasing amounts of free leptin may serve as a link between the adipose tissue and hypothalamic pituitary gonadal axis. 23 The continuous decline of the ratio between sOB-R and leptin throughout childhood and early puberty in both genders is in agreement with this hypothesis. In boys, the ratio decreased in childhood and early puberty, but increased during progression of puberty. The latter suggests a moderately suppressive effect in leptin bioactivity due to the unchanged sOB-R and decreased leptin levels. As leptin appears to act as a direct inhibitory signal for testicular steroidogenesis, reduced free leptin levels may favour the optimal sexual maturation during these pubertal stages in males. 30 To study the effects of different ratios between sOB-R and leptin on the biological actions of this hormone in more detail, we have established and evaluated an in vitro cell culture model using a transfected, OB-Rb overexpressing cell line.
Our investigations revealed that a notable molar excess of the sOB-R significantly inhibits leptin's bioactivity most likely through its competition with the membrane receptor. These suppressive effects were observed at physiologically relevant leptin concentrations of 0.1 nM and 0.5 nM. The 0.1 nM level was related to a lower absolute amount of the sOB-R used in the cell assay in comparison to the investigations performed with 0.5 nM of the hormone. Consequently, the relation between the sOB-R-binding sites and the constant number of binding sites of the membrane receptors of the cells was five-fold lower in the first case. However, despite these changes in the equilibrium conditions of leptin binding, we did not observe significant differences in the relative degree of the 3 H-thymidine uptake for effects of the sOB-R at both leptin levels. Presumably, this alteration was not striking enough for the discrimination of expected effects on the cell proliferation by our assay. Supposing that only free leptin is bioactive, our assay system determined quantities of free hormone that had the potency to operate at the membrane-bound receptor subtypes. However, we cannot fully exclude the fact that sOB-R/ leptin complexes may act directly on these receptors as well. This suggestion is supported by the data of Liu et al, 26 who demonstrated that low amounts of 125 I leptin complexed with the sOB-R were capable of binding to cell membranes. However, leptin action in these cell experiments included all variants of bioactive leptin present in the medium, that is, in contrast to recent assays reflecting immunoreactive leptin levels only. 25, 31 The latter therefore often displayed artificially increased leptin levels due to the competitive interference of endogenous sOB-R with the binding sites of the antibody.
It is well known that obesity is related to increased peripheral levels of leptin indicating a decreased biological effect of the hormone. 32 The basic cause and the exact mechanism of leptin resistance is unclear to date. It remains possible that either a downregulation in leptin receptor density, a dysfunction in signal-transducing activities or defects in postreceptor processes may lead to this effect, and that centrally administered leptin is not fully capable of inducing an adequate response in obese subjects. A role of leptin-binding proteins and in particular of sOB-R as a trigger of leptin resistance has been hypothesized, but not elucidated so far. 33 Considering the data of our cell culture model, we suggest that binding of leptin by sOB-R results in a diminished effect of the total hormone in central and peripheral target tissues. As sOB-R is not detectable in the cerebrospinal fluid (CSF), 34 centrally present leptin may be regulated indirectly by peripherally circulating sOB-R: high sOB-R/leptin ratios decrease the amount of free leptin in the serum and subsequently its potency to pass the blood-brain barrier. This mechanism could act to compensate unnecessary leptin action upon energy deficiency. This model of a compensatory function of the circulating receptor was supported by our data in early childhood and by results from studies of patients with anorexia nervosa. 24 However, in the case of energy excess and low sOB-R/ leptin ratios, as in obesity, our data are not compatible with recent findings that leptin passes the blood-brain barrier by a saturation mechanism leading to decreased CSF/plasma leptin ratios with increasing obesity. [35] [36] [37] Declining ratios of leptin between these two compartments were expected to be the consequence of a diminished receptor number at certain cell membranes of the blood-brain barriers. 12 In this state, the relatively high levels of free leptin in plasma caused by increased leptin secretion from adipose tissue are Soluble leptin receptor and leptin action O Zastrow et al paralleled by low peripheral sOB-R concentrations. This reflects, therefore, rather a compensation mechanism to overcome leptin resistance of a different origin. 38 Besides its central actions, a variety of leptin effects on muscle cells, adipose tissue, liver and other peripheral tissues has been demonstrated in the last few years. 39 Therefore, changes in the peripheral sOB-R/leptin ratio may also modulate these effects. Interestingly, we have to consider the fact that sOB-R may be secreted by the above-mentioned tissues themselves in a proteolytic cleavage process by shedding their extracellular receptor domain. 17 Thus, in the state of energy deficiency, leptin mediated effects, such as an increased glucose uptake in muscle cells 40 as well as a reduction of the glucose release from gluconeogenic precursors in hepatocytes, 41 are prevented by high sOB-R levels, whereas these functions are not affected in states of energy excess.
In conclusion, the biological action of leptin is controlled by its soluble receptor depending on certain metabolic or developmental conditions. At a molar excess of the sOB-R, suppressive effects on leptin action may be important for energy uptake in conditions with a high-energy requirement like in the first years of life or in energy-deficient states. In contrast, obesity or states with energy excess demonstrate an abundance of leptin over sOB-R in the circulation, which does not appear to be crucial for leptin action. In the future, regulatory pathways controlling the sOB-R release into circulation have to be elucidated. By these means, new tools affecting the energy balance of the organism via modulation of leptin action may be established.
